{"code":"M63.849","type":"code","title":"Disorders of muscle in diseases classified elsewhere, unspecified hand","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":["underlying disease, such as:","leprosy (A30.-)","neoplasm (C49.-, C79.89, D21.-, D48.1-)","schistosomiasis (B65.-)","trichinellosis (B75)"],"excludes1":["myopathy in cysticercosis (B69.81)","myopathy in endocrine diseases (G73.7)","myopathy in metabolic diseases (G73.7)","myopathy in sarcoidosis (D86.87)","myopathy in secondary syphilis (A51.49)","myopathy in syphilis (late) (A52.78)","myopathy in toxoplasmosis (B58.82)","myopathy in tuberculosis (A18.09)","dermatopolymyositis (M33.-)","myopathy in amyloidosis (E85.-)","myopathy in polyarteritis nodosa (M30.0)","myopathy in rheumatoid arthritis (M05.32)","myopathy in scleroderma (M34.-)","myopathy in Sjögren's syndrome (M35.03)","myopathy in systemic lupus erythematosus (M32.-)"],"excludes2":["muscular dystrophies and myopathies (G71-G72)"],"isBillable":true,"inclusionTerms":[],"useAdditionalCode":[],"clinicalDefinition":"Disorders of muscle in diseases classified elsewhere, unspecified hand is a billable ICD-10-CM diagnosis code (M63.849). Excludes1 (not coded here): myopathy in cysticercosis (B69.81); myopathy in endocrine diseases (G73.7); myopathy in metabolic diseases (G73.7); myopathy in sarcoidosis (D86.87); myopathy in secondary syphilis (A51.49); myopathy in syphilis (late) (A52.78); myopathy in toxoplasmosis (B58.82); myopathy in tuberculosis (A18.09); dermatopolymyositis (M33.","officialDefinition":"Disorders of muscle in diseases classified elsewhere, unspecified hand is a billable ICD-10-CM diagnosis code (M63.849). Excludes1 (not coded here): myopathy in cysticercosis (B69.81); myopathy in endocrine diseases (G73.7); myopathy in metabolic diseases (G73.7); myopathy in sarcoidosis (D86.87); myopathy in secondary syphilis (A51.49); myopathy in syphilis (late) (A52.78); myopathy in toxoplasmosis (B58.82); myopathy in tuberculosis (A18.09); dermatopolymyositis (M33.-); myopathy in amyloidosis (E85.-); myopathy in polyarteritis nodosa (M30.0); myopathy in rheumatoid arthritis (M05.32); myopathy in scleroderma (M34.-); myopathy in Sjögren's syndrome (M35.03); myopathy in systemic lupus erythematosus (M32.-). Excludes2 (not included here): muscular dystrophies and myopathies (G71-G72). Code first: underlying disease, such as:; leprosy (A30.-); neoplasm (C49.-, C79.89, D21.-, D48.1-); schistosomiasis (B65.-); trichinellosis (B75).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}